The process of autophagy (“self-eating” in Greek) involves the degradation of bulky material (“cargo)” in double-membraned cellular compartments, called autophagosomes, that eventually fuse with lysosomes to destroy the cargo.
By doing so, autophagy contributes to protect cells against danger signals and recycles amino acids and lipids that are released upon lysosomal hydrolysis. Selectivity during autophagy is achieved by specialized autophagy receptors, like p62/SQSTM1, optineurin (OPTN) and FAM134B, that facilitate the recruitment of autophagic membranes to cargo and autophagy adaptors that attract the cellular machinery to autophagosomes.
In these scenarios, autophagy serves cytoprotective roles. However, under certain conditions, extended, prolonged periodes of autophagy or hyper-activation of autophagy can induce cell death (autophagic cell death, ACD). We have studied this by screening a chemical library of autophagy-inducing substances and identified several compounds that selectively induce autophagy and caspase-independent autophagy-dependent cell death in human glioblastoma (Zielke et al 2018) and mouse embryonic fibroblasts (Kinzler et al 2020).
Our current work is focussing on unraveling the mechanisms of drug-induced autophagy and ACD in healthy and in cancer cells using immunofluoresence, CRISPR/Cas9 functional genomic screenings, autophagy reporters, electron microscopy and classical biochemistry.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.